Balance Labs, Inc.
BLNC
$0.2122
$0.029115.89%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 1.52% | 0.88% | |||
| Gross Profit | -1.52% | -0.88% | |||
| SG&A Expenses | 215.38% | -41.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 44.56% | -11.87% | |||
| Operating Income | -44.56% | 11.87% | |||
| Income Before Tax | -91.46% | 13.86% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -91.46% | 13.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -91.46% | 13.86% | |||
| EBIT | -44.56% | 11.87% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -93.48% | 14.81% | |||
| Normalized Basic EPS | -27.27% | 5.71% | |||
| EPS Diluted | -93.48% | 14.81% | |||
| Normalized Diluted EPS | -27.27% | 5.71% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
